Q4 2024 Earnings Call Transcript March 11, 2025 ECARX Holdings, Inc. beats earnings expectations. Reported EPS is $-0.11, ...
The second act of a popular reprogramming factor could maximize the potential of iPSCs in research and regenerative medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback